Aurealis Therapeutics Raises $10 Million Series A To Drive Multi-Factor Bacterial Vectors in Chronic Wounds and Oncology
Kuopio, Finland – March 30th 2023. Aurealis Therapeutics, a synthetic biology company
Source: einnews.com
Stay updated with breaking news from Lactococcus Cremoris. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kuopio, Finland – March 30th 2023. Aurealis Therapeutics, a synthetic biology company